Treating relapsing and remitting forms of multiple sclerosis requires a combination of cognitive and behavioral therapies, physiotherapy, lifestyle changes, and medication. Several pharmaceutical companies have clinical development plans in the works for the formulation of novel therapies to treat MS. Here are some of the available medications:
1. Aubagio (Oral)
Aubagio (chemically known as teriflunomide), marketed by Sanofi, is an active metabolite of the compound leflunomide and is a pyrimidine synthesis inhibitor.
Recently, researchers at the University of Texas Health Science Center at Houston, in collaboration with various institutions from north America and Europe, found that teriflunomide (Aubagio) is well-tolerated and efficient for the long-term treatment of multiple sclerosis (MS).